PRAS40 Connects Microenvironmental Stress Signaling to Exosome-Mediated Secretion

REFERENCES

• Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colás E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Krämer-Albers EM, Laitinen S, Lässer C, Lener T, Ligeti E, Linē A, Lipps G, Llorente A, Lötvall J, Manèek-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-'t Hoen EN, Nyman TA, O'Driscoll L, Olivan M, Oliveira C, Pállinger É, Del Portillo HA, Reventós J, Rigau M, Rohde E, Sammar M, Sánchez-Madrid F, Santarém N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O. 2015. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4:27066. https://doi.org/10.3402/jev.v4.27066.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. 2013. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383. https://doi.org/10.1083/jcb.201211138.
   PubMed Web of Science ®Google Scholar
• Harding C, Heuser J, Stahl P. 1983. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97:329–339. https://doi.org/10.1083/jcb.97.2.329.
   PubMed Web of Science ®Google Scholar
• Pan BT, Teng K, Wu C, Adam M, Johnstone RM. 1985. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 101:942–948. https://doi.org/10.1083/jcb.101.3.942.
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. 1987. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262:9412–9420.
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. 2016. Communication by extracellular vesicles: where we are and where we need to go. Cell 164:1226–1232. https://doi.org/10.1016/j.cell.2016.01.043.
   PubMed Web of Science ®Google Scholar
• Kucharzewska P, Belting M. 2013. Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. J Extracell Vesicles 5:2.
   Google Scholar
• Théry C, Zitvogel L, Amigorena S. 2002. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569–579.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, Théry C, Wauben MH, Hochberg F. 2013. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2:20360. https://doi.org/10.3402/jev.v2i0.20360.
   PubMedGoogle Scholar
• Colombo M, Raposo G, Théry C. 2014. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289. https://doi.org/10.1146/annurev-cellbio-101512-122326.
   PubMed Web of Science ®Google Scholar
• Nolte-‘tHoen EN, Buermans HP, Waasdorp M, Stoorvogel W, Wauben MH, Hoen PA. 2012. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res 40:9272–9285. https://doi.org/10.1093/nar/gks658.
   PubMedGoogle Scholar
• Yuana Y, Sturk A, Nieuwland R. 2013. Extracellular vesicles in physiological and pathological conditions. Blood Rev 27:31–39. https://doi.org/10.1016/j.blre.2012.12.002.
   PubMed Web of Science ®Google Scholar
• Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM, Nitadori-Hoshino A. 2012. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:883–891. https://doi.org/10.1038/nm.2753.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Mark MT, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S. 2015. Tumor exosome integrins determine organotropic metastasis. Nature 527:329–335. https://doi.org/10.1038/nature15756.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, Wang H. 2015. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527:100–104. https://doi.org/10.1038/nature15376.
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B. 2010. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12:19–30. https://doi.org/10.1038/ncb2000.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Campbell EC, Lucocq J, Riches A, Powis SJ. 2013. Monitoring the Rab27 associated exosome pathway using nanoparticle tracking analysis. Exp Cell Res 319:1706–1713. https://doi.org/10.1016/j.yexcr.2012.10.006.
   PubMed Web of Science ®Google Scholar
• Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, Ostrowski M, Théry C. 2012. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumour microenvironment and can promote tumour progression. Cancer Res 72:4920–4930. https://doi.org/10.1158/0008-5472.CAN-12-0925.
   PubMed Web of Science ®Google Scholar
• Sinha S, Daisuke H, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, Tyska MJ, Weaver AM. 2016. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol 214:197–213. https://doi.org/10.1083/jcb.201601025.
   PubMed Web of Science ®Google Scholar
• Kovacina KS, Park GY, Bae SS, Guzzetta AW, Schaefer E, Birnbaum MJ, Roth RA. 2003. Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem 278:10189–10194. https://doi.org/10.1074/jbc.M210837200.
   PubMed Web of Science ®Google Scholar
• Saito A, Narasimhan P, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH. 2004. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J Neurosci 24:1584–1593. https://doi.org/10.1523/JNEUROSCI.5209-03.2004.
   PubMed Web of Science ®Google Scholar
• Shimaya A, Kovacina KS, Roth RA. 2004. On the mechanism for neomycin reversal of wortmannin inhibition of insulin stimulation of glucose uptake. J Biol Chem 279:55277–55282. https://doi.org/10.1074/jbc.M411540200.
   PubMedGoogle Scholar
• Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. 2007. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9:316–323. https://doi.org/10.1038/ncb1547.
   PubMed Web of Science ®Google Scholar
• Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. 2010. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141:290–303. https://doi.org/10.1016/j.cell.2010.02.024.
   PubMed Web of Science ®Google Scholar
• Fonseca BD, Smith EM, Lee VH, MacKintosh C, Proud CG. 2007. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signalling downstream of this complex. J Biol Chem 282:24514–24524. https://doi.org/10.1074/jbc.M704406200.
   PubMed Web of Science ®Google Scholar
• Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, Eguchi S, Miyamoto T, Hara K, Takehana K, Avruch J, Kikkawa U, Yonezawa K. 2007. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem 282:20329–20339. https://doi.org/10.1074/jbc.M702636200.
   PubMed Web of Science ®Google Scholar
• Thedieck K, Polak P, Kim ML, Molle KD, Cohen A, Jenö P, Arrieumerlou C, Hall MN. 2007. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS One 2:e1217. https://doi.org/10.1371/journal.pone.0001217.
   PubMed Web of Science ®Google Scholar
• Wang L, Harris TE, Roth RA, Lawrence JC. 2007. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282:20036–20044. https://doi.org/10.1074/jbc.M702376200.
   PubMed Web of Science ®Google Scholar
• Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM. 2007. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25:903–915. https://doi.org/10.1016/j.molcel.2007.03.003.
   PubMed Web of Science ®Google Scholar
• Wang L, Harris TE, Lawrence JC. 2008. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediate phosphorylation. J Biol Chem 283:15619–15627. https://doi.org/10.1074/jbc.M800723200.
   PubMed Web of Science ®Google Scholar
• Zhang F, Beharry ZM, Harris TE, Lilly MB, Smith CD, Mahajan S, Kraft AS. 2009. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Cancer Biol Ther 8:846–853. https://doi.org/10.4161/cbt.8.9.8210.
   PubMed Web of Science ®Google Scholar
• Fonseca BD, Lee VH, Proud CG. 2008. The binding of PRAS40 to 14-3-3 proteins is not required for activation of mTORC1 signalling by phorbol esters/ERK. Biochem J 411:141–149. https://doi.org/10.1042/BJ20071001.
   PubMed Web of Science ®Google Scholar
• Cheng CF, Fan J, Fedesco M, Guan S, Li Y, Bandyopadhyay B, Bright AM, Yerushalmi D, Liang M, Chen M, Han YP, Woodley DT, Li W. 2008. Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol 28:3344–3358. https://doi.org/10.1128/MCB.01287-07.
   PubMed Web of Science ®Google Scholar
• Cheng CF, Sahu D, Tsen F, Zhao Z, Fan J, Kim R, Wang X, O'Brien K, Li Y, Kuang Y, Chen M, Woodley DT, Li W. 2011. A fragment of secreted Hsp90alpha carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice. J Clin Investig 121:4348–4361. https://doi.org/10.1172/JCI46475.
   PubMed Web of Science ®Google Scholar
• Li W, Sahu D, Tsen F. 2012. Secreted heat shock protein-90 (Hsp90) in wound healing and cancer. Biochim Biophys Acta 1823:730–741. https://doi.org/10.1016/j.bbamcr.2011.09.009.
   PubMed Web of Science ®Google Scholar
• Li Y, Fan J, Chen M, Li W, Woodley DT. 2006. Transforming growth factor-alpha: a major human serum factor that promotes human keratinocyte migration. J Investig Dermatol 126:2096–2105. https://doi.org/10.1038/sj.jid.5700350.
   PubMedGoogle Scholar
• Li W, Li Y, Guan S, Fan J, Cheng CF, Chen M, Woodley DT. 2007. Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. EMBO J 26:1221–1233. https://doi.org/10.1038/sj.emboj.7601579.
   PubMed Web of Science ®Google Scholar
• Woodley DT, Li Y, Fan J, Cheng JC-F, Chen M, Li W. 2009. Participation of LRP-1 in hypoxia hsp90α autocrine signaling to promote cell motility. J Cell Sci 122:1495–1498. https://doi.org/10.1242/jcs.047894.
   PubMed Web of Science ®Google Scholar
• Vincent EE, Elder DJE, Thomas EC, Phillips L, Morgan C, Pawade J, Sohail M, May MT, Hetzel MR, Tavaré JM. 2011. Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br J Cancer 104:1755–1761. https://doi.org/10.1038/bjc.2011.132.
   PubMed Web of Science ®Google Scholar
• Yu X, Harris SL, Levine AJ. 2006. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66:4795–4801. https://doi.org/10.1158/0008-5472.CAN-05-4579.
   PubMed Web of Science ®Google Scholar
• Zou M, Bhatia A, Dong H, Jayaprakash P, Guo J, Sahu D, Hou Y, Tsen F, Tong C, O'Brien K, Situ A, Schimidt T, Chen M, Ying Q, Ulmer T, Woodley D, Li W. 2016. Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression. Oncogene 36:2160–2171. https://doi.org/10.1038/onc.2016.375.
   PubMedGoogle Scholar
• Sahu D, Zhao Z, Tsen F, Cheng CF, Park R, Situ AJ, Dai J, Eginli A, Shams S, Chen M, Ulmer TS. 2012. A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α–positive tumors. Mol Biol Cell 23:602–613. https://doi.org/10.1091/mbc.E11-06-0575.
   PubMed Web of Science ®Google Scholar
• Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A. 2014. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26:707–721. https://doi.org/10.1016/j.ccell.2014.09.005.
   PubMed Web of Science ®Google Scholar
• Huang B, Porter G. 2005. Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis. Acta Pharmacol Sin 26:1253–1258. https://doi.org/10.1111/j.1745-7254.2005.00184.x.
   PubMed Web of Science ®Google Scholar
• Nascimento EB, Snel M, Guigas B, van der Zon GC, Kriek J, Maassen JA, Jazet IM, Diamant M, Ouwens DM. 2010. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1. Cell Signal 22:961–967. https://doi.org/10.1016/j.cellsig.2010.02.002.
   PubMed Web of Science ®Google Scholar
• Pino MS, Shrader M, Baker CH, Cognetti F, Xiong HQ, Abbruzzese JL, McConkey DJ. 2006. Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines. Cancer Res 66:3802–3812. https://doi.org/10.1158/0008-5472.CAN-05-3753.
   PubMed Web of Science ®Google Scholar
• Garcia-Maceira P, Mateo J. 2009. Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene 28:313–324. https://doi.org/10.1038/onc.2008.398.
   PubMed Web of Science ®Google Scholar
• Jia CH, Li M, Liu J, Zhao L, Lin J, Lai PL, Zhou X, Zhang Y, Chen ZG, Li HY, Liu AL, Yang CL, Gao TM, Jiang Y, Can XC. 2013. IKK-β mediates hydrogen peroxide induced cell death through p85 S6K1. Cell Death Differ 20:248–258. https://doi.org/10.1038/cdd.2012.115.
   PubMedGoogle Scholar
• Wiza C, Nascimento EB, Ouwens DM. 2012. Role of PRAS40 in Akt and mTOR signalling in health and disease. Am J Physiol Endocrinol Metab 302:E1453–E1460. https://doi.org/10.1152/ajpendo.00660.2011.
   PubMed Web of Science ®Google Scholar
• Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Théry C. 2016. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Nat Acad Sci USA 113:E968–E977. https://doi.org/10.1073/pnas.1521230113.
   PubMed Web of Science ®Google Scholar
• Madhunapantula SV, Sharma A, Robertson GP. 2007. PRAS40 deregulates apoptosis in malignant melanoma. Cancer Res 67:3626–3636. https://doi.org/10.1158/0008-5472.CAN-06-4234.
   PubMed Web of Science ®Google Scholar
• Huang L, Nakai Y, Kuwahara I, Matsumoto K. 2012. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma. Cancer Res 72:1260–1269. https://doi.org/10.1158/0008-5472.CAN-11-2254.
   PubMed Web of Science ®Google Scholar
• Kazi AA, Lang CH. 2010. PRAS40 regulates protein synthesis and cell cycle in C2C12 myoblasts. Mol Med 16:359. https://doi.org/10.2119/molmed.2009-00168.
   PubMed Web of Science ®Google Scholar
• Havel JJ, Li Z, Cheng D, Peng J, Fu H. 2015. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Oncogene 34:1487–1498. https://doi.org/10.1038/onc.2014.91.
   PubMed Web of Science ®Google Scholar
• Yu F, Narasimhan P, Saito A, Liu J, Chan PH. 2008. Increased expression of a proline-rich Akt substrate (PRAS40) in human copper/zinc-superoxide dismutase transgenic rats protects motor neurons from death after spinal cord injury. J Cereb Blood Flow Metab 28:44–52. https://doi.org/10.1038/sj.jcbfm.9600501.
   PubMed Web of Science ®Google Scholar
• Shin MJ, Kim DW, Jo HS, Cho SB, Park JH, Lee CH, Yeo EJ, Choi YJ, Kim JA, Hwang JS, Sohn EJ. 2016. Tat-PRAS40 prevent hippocampal HT-22 cell death and oxidative stress induced animal brain ischemic insults. Free Radic Biol Med 97:250–262. https://doi.org/10.1016/j.freeradbiomed.2016.06.009.
   PubMed Web of Science ®Google Scholar
• Amzallag N, Passer BJ, Allanic D, Segura E, Théry C, Goud B, Amson R, Telerman A. 2004. TSAP6 facilitates the secretion of translationally controlled tumour protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem 279:46104–46112. https://doi.org/10.1074/jbc.M404850200.
   PubMed Web of Science ®Google Scholar
• Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, Vidal M, Amson R, Telerman A. 2008. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ 15:1723–1733. https://doi.org/10.1038/cdd.2008.104.
   PubMed Web of Science ®Google Scholar
• Dong H, Zou M, Bhatia A, Jayaprakash P, Hofman F, Ying Q, Chen M, Woodley DT, Li W. 2016. Breast cancer MDA-MB-231 cells use secreted heat shock protein-90alpha (Hsp90α) to survive a hostile hypoxic environment. Sci Rep 6:20605. https://doi.org/10.1038/srep20605.
   PubMed Web of Science ®Google Scholar
• Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. 2005. Induction of heat shock proteins in B-cell exosomes. J Cell Sci 118:3631–3638. https://doi.org/10.1242/jcs.02494.
   PubMed Web of Science ®Google Scholar
• Wang T, Gilkes DM, Takano N, Xiang L, Luo W, Bishop CJ, Chaturvedi P, Green JJ, Semenza GL. 2014. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 111:E3234–3242.
   PubMed Web of Science ®Google Scholar